1. Home
  2. MDXG vs NBN Comparison

MDXG vs NBN Comparison

Compare MDXG & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • NBN
  • Stock Information
  • Founded
  • MDXG 2006
  • NBN 1872
  • Country
  • MDXG United States
  • NBN United States
  • Employees
  • MDXG N/A
  • NBN N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • NBN Major Banks
  • Sector
  • MDXG Health Care
  • NBN Finance
  • Exchange
  • MDXG Nasdaq
  • NBN Nasdaq
  • Market Cap
  • MDXG 1.1B
  • NBN 853.5M
  • IPO Year
  • MDXG N/A
  • NBN N/A
  • Fundamental
  • Price
  • MDXG $6.94
  • NBN $109.01
  • Analyst Decision
  • MDXG Buy
  • NBN Buy
  • Analyst Count
  • MDXG 1
  • NBN 2
  • Target Price
  • MDXG $12.00
  • NBN $97.50
  • AVG Volume (30 Days)
  • MDXG 439.7K
  • NBN 66.4K
  • Earning Date
  • MDXG 10-29-2025
  • NBN 10-28-2025
  • Dividend Yield
  • MDXG N/A
  • NBN 0.04%
  • EPS Growth
  • MDXG N/A
  • NBN 32.98
  • EPS
  • MDXG 0.21
  • NBN 10.08
  • Revenue
  • MDXG $363,774,000.00
  • NBN $204,086,000.00
  • Revenue This Year
  • MDXG $12.68
  • NBN $17.75
  • Revenue Next Year
  • MDXG $8.18
  • NBN $9.91
  • P/E Ratio
  • MDXG $32.78
  • NBN $10.78
  • Revenue Growth
  • MDXG 6.85
  • NBN 33.67
  • 52 Week Low
  • MDXG $5.47
  • NBN $68.89
  • 52 Week High
  • MDXG $10.14
  • NBN $112.22
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.17
  • NBN 57.91
  • Support Level
  • MDXG $6.89
  • NBN $107.94
  • Resistance Level
  • MDXG $7.14
  • NBN $111.50
  • Average True Range (ATR)
  • MDXG 0.18
  • NBN 2.37
  • MACD
  • MDXG -0.04
  • NBN -0.59
  • Stochastic Oscillator
  • MDXG 29.55
  • NBN 28.03

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the US. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived primarily from interest and dividends from the bank.

Share on Social Networks: